Cleared Special

K210752 - HydroMARK Breast Biopsy Site Marker (FDA 510(k) Clearance)

Apr 2021
Decision
30d
Days
Class 2
Risk

K210752 is an FDA 510(k) clearance for the HydroMARK Breast Biopsy Site Marker. This device is classified as a Marker, Radiographic, Implantable (Class II - Special Controls, product code NEU).

Submitted by Devicor Medical Products, Inc. (Cincinnati, US). The FDA issued a Cleared decision on April 14, 2021, 30 days after receiving the submission on March 15, 2021.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4300.

Submission Details

510(k) Number K210752 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2021
Decision Date April 14, 2021
Days to Decision 30 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NEU — Marker, Radiographic, Implantable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4300